Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.

Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Abstract Text:

    j m phillipsJ M Phillips,r s ehrlichmanR S Ehrlichman,s j siegelS J Siegel,

    Cigarette smoking is significantly more prevalent in individuals with schizophrenia than in non-affected populations. Certain neurocognitive deficits and disruptions common in schizophrenia may be altered by smoking, leading to the hypothesis that schizophrenics engage in smoking behavior to alleviate specific neurocognitive symptoms of the disorder. Additionally, research suggests that individuals with schizophrenia have altered auditory event-related potentials (ERPs) and abnormalities in evoked gamma oscillations which are both indices of sensory information processing. This study was conducted to examine the effect of acute administration of nicotine and the non-specific nicotinic antagonist mecamylamine on the P20 and N40 components of the ERP and evoked gamma oscillations in mice. Acute nicotine (1 mg/kg) significantly increased P20 amplitude, an effect that was blocked by pretreatment with mecamylamine (2 mg/kg). Additionally, acute nicotine increased the normal burst of evoked gamma following an auditory stimulus. The increase in evoked gamma was also blocked by mecamylamine pretreatment. Although acute nicotine decreased amplitude of the N40 component, this decrease was not attenuated by mecamylamine. These results replicate findings that nicotine may enhance early sensory information processing through the nicotinic acetylcholinergic receptor system in an established model (ERPs) and extend these findings in an emerging, novel model (evoked gamma oscillations) of sensory information processing. The results also support the hypothesis that nicotine may be beneficial to individuals with deficits in neurocognitive functions, such as those suffering from schizophrenia.

    Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Publishing Authors By Initials

    jm phillipsJM Phillips,rs ehrlichmanRS Ehrlichman,sj siegelSJ Siegel,

    For similar disorders of environmental origin: substance-related disorders: tobacco use disorder research abstracts see: disorders of environmental origin: substance-related disorders: tobacco use disorder research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Neuroscience

    VOLUME: 144

    Page Numbers: 1314-23

    Journal Abbreviation: Neuroscience

    ISSN: 0306-4522

    DAY: 19

    MONTH: 12

    YEAR: 2006

    Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7605074

    Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Keywords Mesh Terms:

    KEYWORDS: Tobacco Use Disorder

    MESH TERMS: physiopathology

    Chemical & Substance for Abstract: Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Information

    Substance Name: Mecamylamine

    Registry Number: 60-40-2

    Grant and Affiliation Information for Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.

    AFFILIATION: Department of Psychiatry, University of Pennsylvania, Translational Research Laboratories, Room 2223, 125 South 31st Street, Philadelphia, PA 19104, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIMH

    GRANT: P50 MH064045-065134

    ACRONYM: MH

    MEDLINETA: Neuroscience

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News